Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.5M Sell
528,015
-62,941
-11% -$6.92M 1% 29
2026
Q1
$62.1M Sell
590,956
-113,589
-16% -$13.3M 1.22% 20
2025
Q4
$87.9M Buy
704,545
+24,463
+4% +$2.91M 1.65% 12
2025
Q3
$81.5M Sell
680,082
-87,867
-11% -$9.28M 1.54% 14
2025
Q2
$70.5M Buy
767,949
+32,646
+4% +$2.98M 1.42% 16
2025
Q1
$64.7M Sell
735,303
-118,663
-14% -$11.7M 1.39% 12
2024
Q4
$79M Buy
853,966
+5,603
+0.7% +$539K 1.62% 11
2024
Q3
$78.7M Buy
848,363
+33,744
+4% +$2.83M 1.55% 11
2024
Q2
$61.1M Buy
814,619
+25,597
+3% +$2.04M 1.27% 21
2024
Q1
$68.1M Buy
+789,022
New +$60.3M 1.41% 16

Other funds holding CRH

Cannell & Spears's CRH Position: Q2 2026 in Review

Cannell & Spears reduced its CRH (CRH) stake by 11% in Q2 2026, selling an estimated $6.92M and leaving 528,015 shares worth $56.5M. The position accounts for 1% of the portfolio, ranked #29.

Cannell & Spears first reported a position in CRH in Q1 2024 and has held it in 10 quarters since. The position peaked at $87.9M in Q4 2025. 1,030 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Cannell & Spears held 528,015 shares of CRH worth $56.5M as of Q2 2026.
  • Cannell & Spears sold 62,941 CRH shares in Q2 2026, an estimated $6.92M.
  • CRH made up 1% of Cannell & Spears's portfolio in Q2 2026, its #29 holding.
  • Cannell & Spears first reported a position in CRH in Q1 2024 and has held it in 10 quarters since.
  • Cannell & Spears's CRH position peaked at $87.9M in Q4 2025.
  • 1,030 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.